Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02875327 · ClinicalTrials.gov registry record

Linkage of Medicaid Enrollment Information to Surveillance, Epidemiology and End Results Data

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
3,217,145
Enrollment target

NCT02875327: Completed study, sponsored by National Cancer Institute (NCI).

NCT02875327 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 3,217,145 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02875327 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
3,217,145 participants
Enrollment target

Study Summary

Background: The SEER database collects data about people with cancer. SEER stands for Surveillance, Epidemiology, and End Results. Medicaid is a kind of health insurance. It is for people who have low income or serious medical needs. Many studies have shown that Medicaid recipients with cancer are more likely to be diagnosed later in the disease than people with other insurance. They are also less likely to get treatment. Researchers want to compare Medicaid data and SEER data. They want to make this available to other scientists. Objectives: To link people in the SEER database to Medicaid data for the years around their cancer diagnosis. To create a file that contains SEER case numbers linked to Medicaid numbers. Eligibility: No people are enrolled in this study. Design: The SEER finder file will be securely uploaded to the CMS Data Center. The finder file will be matched against the Medicaid Personal Summary file at the CMS Data Center. If participants appear in both the SEER file and Medicaid file, their data will be extracted. The dates of Medicaid data will be compared with the SEER date of diagnosis. Researchers will see if the Medicaid dates fall in certain periods. These are 12 months before, the month of, and 11 months after diagnosis. If participants are eligible for Medicaid for these periods, a flag will be created in the file. It will note the participants is eligible and why. The SEER finder file will be destroyed. The only data saved will be: Each participant's unique random SEER case number linked to their Medicaid number Monthly flags about Medicaid eligibility

Trial Details

FieldValue
Enrollment Target 3,217,145 participants
Start Date 2016-08-05
Est. Completion 2020-05-20
National Cancer Institute (NCI)

3,257 total trials

What the finished NCT02875327 record still lists

NCT02875327 is an observational study that tracks outcomes without assigning an intervention. Its 3,217,145 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT02875327 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02875327 about?

NCT02875327 is a clinical study titled "Linkage of Medicaid Enrollment Information to Surveillance, Epidemiology and End Results Data". Background: The SEER database collects data about people with cancer. SEER stands for Surveillance, Epidemiology, and End Results. Medicaid is a kind of health insurance. It is for people who have low income or serious medical needs. Many studies have shown that Medicaid recipients with cancer are ...

What is the current status of trial NCT02875327?

This trial is currently completed. The enrollment target is 3,217,145 participants. The study started on 2016-08-05. Estimated completion is 2020-05-20.

Who is sponsoring clinical trial NCT02875327?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06803498 · 3,000,000 participants

    Delivery Room Intervention and Evaluation Network

  • NCT02693223 · 3,892,063 participants

    Get With the Guidelines-Stroke Registry

  • NCT03813862 · 2,000,000 participants

    Observational Pharmaco-Epidemiology Research & Analysis

  • NCT06057181 · 2,000,000 participants

    Helix Research Network

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02875327, the US trial registry maintained by the National Library of Medicine. NCT02875327 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.